Scandinavian innovation projects supported by EIT Health

2017-01-11

An improved method to detect prostate cancer is the focus of one of the projects based in Scandinavia receiving funding in the EIT Health Innovation by Design Call 2017.

STHLM3 Risk Score is a new application to calculate individual prostate cancer risk. Evaluated in 58 000 men, STHLM3 Risk Score finds 20% more aggressive cancers and show potential to considerably reduce the number of unnecessary biopsies. Combining genetic and protein biomarkers with clinical data in a multivariate algorithm, this application is developed in a joint clinical research program between Thermo Fisher Scientific and Karolinska Institutet.

Further development of STHLM3 Risk Score will be performed in international collaboration with partners in Belgium and the Netherlands, with financial support granted in the EIT Health Innovation by Design Call 2017. The next step is to adopt the application to different HCP needs, individual men’s need and improvement by big data analyses.

The project is currently looking for new Partners/Expertise, please e-mail Per.Matsson@Thermofisher.com for more information.

EIT Health also awards 1,5 million Euro to The Health Movement, a Swedish initiative to develop new methods of preventing lifestyle diseases that currently require a large proportion of healthcare resources. The Health Movement is conducted by the Karolinska Institutet, MSD, RISE and the Stockholm County Council. International partners are located in Barcelona (ES), Birmingham (UK), Budapest (HU) and Rotterdam (NL).

In addition to STHLM3 and The Health Movement, the projects We@Work and HOOP with Scandinavian partners participating as members will receive EIT Health funding.

More information STHLM3
More information The Health Movement (Pre-D)
More information We@Work
More information HOOP

Latest updates